Terns Pharmaceuticals, Inc.
No trades
Price target
46.510.000.00%
The 9 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
430 EPS for the last quarter is −0.23 EUR despite the estimation of −0.25 EUR. In the next quarter EPS is expected to reach −0.26 EUR. Track more of Terns Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Terns Pharmaceuticals, Inc. revenue is expected to reach 0.00 EUR. Check out Terns Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, 430 price target is 46.51 EUR with a max estimate of 60.05 EUR and a min estimate of 19.73 EUR. Check if this forecast comes true in a year, meanwhile watch Terns Pharmaceuticals, Inc. stock price chart and keep track of the current situation with 430 news and stock market news.
We've gathered opinions of 10 analysts rating 430 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.